Cannafarm Investment LTD — an international company that allows you to invest in the production of medicinal cannabis.

5 years of successful work — investment capital over

$ 215 000 000
Company documents
Regisration: 14483969

We produce medicinal cannabis for pharmaceutical companies. In 2020, we developed a cultivation technology that allows us to harvest crops every 35 days. In early 2021, the company's management made the decision to create an investment proposal based on this technology. In 2022, Cannafarm Investment LTD was established, introducing its cultivation technology and investment proposal to the general public.

We produce raw materials for an extensive list of medicines

Continuing to uphold a high level of raw material quality, Cannafarm has become one of the leading companies in the production of medical cannabis. Our raw materials are utilized by pharmaceutical companies specializing in manufacturing pharmaceutical products derived from hemp, such as Nabilone, Cesamet, Dronabinol-Marinol, Nabiximols, Epidiolex, and more. These medications are in high demand in the global pharmaceutical market.

Why choose

  • Fast cash turnover is achieved thanks to our unique cultivation technology, which enables us to harvest a crop every 35 days.
  • Flexible investment
  • Our raw materials are used to produce a wide range of drugs used to treat and prevent conditions such as cancer, HIV, AIDS, Tourette syndrome, and more.
  • High-tech automated plantations provide employment for more than 2000 people.
  • International team of key specialists and experts with many years of experience.
  • Sustainable financial model of the investment proposal, confirmed by an official audit.
  • Our production is 100% organic. We do not use harmful chemicals or impurities, and there are no emissions of harmful substances into the environment.
  • A simple, understandable profit-making scheme and high margins of the final product.
  • No risk: Cannafarm is officially registered and licensed to raise investment funds.
  • Generous affiliate program: Earn 5% of the amount of deposits from investors you invite.


Q1 2022
  • Implement the final stage of the reconstruction of production lines, utilizing our advanced 35 days cannabis cultivation technologies, aiming to ensure maximum production efficiency.
  • Release a comprehensive investment proposal prepared in accordance with all necessary legal and legislative norms to attract investors and ensure the financial stability of our company.
  • Begin active preparations for the construction of advanced plantations in Thailand, including conducting research, selecting a location, and planning infrastructure to guarantee a successful launch of our operations in this region.
  • Sign a transportation agreement for our products with Integrated Security Services, a leading company in integrated security services.
Q2 2022
  • Successfully undergo an audit by DELOITTE TOUCHE TOHMATSU LIMITED, a leading international audit and consulting company, to confirm our transparency, reliability, and adherence to quality standards.
  • Finalize an important insurance agreement with the reputable insurance company AmTrust Financial Services, Inc., to protect our assets and minimize risks associated with our activities.
  • Systematically recruit 100 highly skilled employees who will be responsible for the launch and efficient operation of our plantations in Thailand to ensure stability and quality in production processes.
  • Implementation of the project to integrate BTC and ETH networks.
Q3 2022
  • Successfully launch our own research center, which will be the main source of innovations, developments, and improvements in the cannabis industry, with a focus on improving product quality and developing new technologies.
  • Organize the launch of our plantation in Thailand, where we will produce high-quality cannabis using advanced cultivation methods to meet the needs of our customers and establish a strong presence in the local and international markets.
  • Enter the southern markets for distillate distribution, offering high-quality cannabis-based products for a wide range of industrial and medical applications.
  • Implementation of the project to integrate USDT TRC20 and USDT ERC20 networks.
Q4 2022
  • Increase the investment capital of our company to $150,000,000 by attracting additional resources and investors to ensure financial strength and realize our ambitious growth and development plans.
  • Begin the sale of auxiliary products, including fertilizers, pesticides, and other related goods, to offer a complete range of products and services that support the cultivation process and provide optimal conditions for plant growth and development.
  • Conduct a thorough security check of inter-network bridges to ensure protection against potential threats and risks.
  • Implementation of the project to integrate BNB and LTC networks.
Q1 2023
  • Expand operations at our plantations in Thailand, increasing production capacity and optimizing processes to meet the growing demand for our products.
  • Redesign our website to provide a better user experience and improve the representation of our company and services.
Q2 2023
  • Implement a new advanced DDoS protection system to ensure continuous and reliable operation of our online resources.
  • Launch a strategic initiative for a complete transition of our plantations to the use of renewable energy sources by 2026.
  • Initiate the construction of our first plantation in Denmark, equipped with advanced technologies and infrastructure, to expand our geographical presence and meet the demand for our products in Europe and other regions of the world.
Q3 2023
  • Launch a large-scale campaign to recruit and attract 300 qualified professionals who will form the core of our team and lead the launch of our plantations in Denmark and Portugal.
  • Strengthen our market position and increase competitiveness by actively participating in industry exhibitions and conferences, as well as establishing partnerships with key stakeholders and organizations.
  • Form strategic partnerships with major funds, including venture capital and investment funds, to gain access to additional resources, expertise, and expand our network of contacts.
Q4 2023
  • Implement a plan to attract additional investment capital of $300,000,000 to support our strategic initiatives and ensure financial stability and growth of the company.
  • Launch new product lines, including concentrates, edibles, cosmetics, and medical products based on cannabis, to expand our product range and meet the diverse needs of the market.
  • Develop our international distribution network by establishing strategic partnerships with key players in various regions of the world. We aim to penetrate new markets and increase our global presence, ensuring the availability and accessibility of our products to customers worldwide.
Have a question?

Have a question? Please read our FAQ. If you have any remaining questions, please get in touch with us.